Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.

Winkler MT, Bushey RT, Gottlin EB, Campa MJ, Guadalupe ES, Volkheimer

AD, Weinberg JB, Patz EF Jr.

PLoS One. 2017 Jun 28;12(6):e0179841. doi:

10.1371/journal.pone.0179841. eCollection 2017.

PMID: 28658265 [PubMed – in process] Free PMC Article

Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.

Wang Y, Sun SN, Liu Q, Yu YY, Guo J, Wang K, Xing BC, Zheng QF, Campa

MJ, Patz EF Jr, Li SY, He YW.

Cancer Discov. 2016 Sep;6(9):1022-35. doi:

10.1158/2159-8290.CD-15-1412. Epub 2016 Jun 13.

PMID: 27297552 [PubMed – in process]

A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.

Bushey RT, Moody MA, Nicely NL, Haynes BF, Alam SM, Keir ST, Bentley

RC, Roy Choudhury K, Gottlin EB, Campa MJ, Liao HX, Patz EF Jr.

Cell Rep. 2016 May 17;15(7):1505-13. doi: 10.1016/j.celrep.2016.04.038.

Epub 2016 May 5.

PMID: 27160908 [PubMed – in process] Free PMC Article

Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.

Campa MJ, Moody MA, Zhang R, Liao HX, Gottlin EB, Patz EF Jr.

Cancer Immunol Immunother. 2016 Feb;65(2):171-80. doi:

10.1007/s00262-015-1787-0. Epub 2016 Jan 6.

PMID: 26739486 [PubMed – indexed for MEDLINE]

Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy.

Campa MJ, Gottlin EB, Bushey RT, Patz EF Jr.

Cancer Immunol Res. 2015 Dec;3(12):1325-32. doi:

10.1158/2326-6066.CIR-15-0122. Epub 2015 Jul 27.

PMID: 26216416 [PubMed – indexed for MEDLINE] Free Article

The Association of Intratumoral Germinal Centers with early-stage non-small cell lung cancer.

Gottlin EB, Bentley RC, Campa MJ, Pisetsky DS, Herndon JE 2nd, Patz EF

Jr..

J Thorac Oncol. 2011 Oct;6(10):1687-90. doi:

10.1097/JTO.0b013e3182217bec..

PMID: 21642860 [PubMed – indexed for MEDLINE] Free Article

Complement factor H autoantibodies are associated with early stage NSCLC.

Amornsiripanitch N, Hong S, Campa MJ, Frank MM, Gottlin EB, Patz EF Jr.

Clin Cancer Res. 2010 Jun 15;16(12):3226-31. doi:

10.1158/1078-0432.CCR-10-0321. Epub 2010 Jun 1.

PMID: 20515868 [PubMed – indexed for MEDLINE] Free PMC Article

Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.

Petersen RP, Campa MJ, Sperlazza J, Conlon D, Joshi MB, Harpole DH Jr,

Patz EF Jr.

Cancer. 2006 Dec 15;107(12):2866-72.

PMID: 17099880 [PubMed – indexed for MEDLINE] Free Article